According to Bloomberg.com, Mexico’s Genomma Lab Internacional SAB rose the most in July as Chief Executive Officer Rodrigo Herrera said the company was on pace to meet its sales growth projections this year.
The drug company is “comfortable” with the forecast of net sales growth of 5.2 percent in 2015, Herrera said in a phone interview with Bloomberg.com on Friday July 17th.
Its fourth-quarter results shocked shareholder Westwood International Advisors Inc., according to Richard Dolhun, an analyst at the firm. Genomma is due to publish its second-quarter earnings and hold a conference call with investors this week.
“We’re going to hold their feet to the fire,” Dolhun, whose firm oversees $5 billion in equities including Genomma, said by phone. “They have to have a tight message. They have to hit on what they’ve promised.”
Shares of Genomma increased 3.1 percent to 16.29 pesos at 12:35 p.m. in Mexico City. The benchmark IPC equity index rose 0.6 percent on Monday July 20th.
more recommended stories
Prisma Hotel Group announces investment of 357 million for remodeling hotels nationwide
With the objective of always providing.
Trump’s ‘Tent Cities’: where unaccompanied minors are kept in South Texas
According to Esquire: Beyond the moral and.
“Mayas y Piratas” Festival in Chetumal
The Bay of Chetumal will host.
The current ESAY premises will be turned into the new University of the Arts
“The transformation of the Higher School.
Growth in tourism is expected in Valladolid during the summer holiday season
After carrying out various promotional activities,.
TIME Magazine Powerful Cover: Welcome to America
It is of public knowledge, Donald.
More employment opportunities in Yucatán
Yucatan registered a favorable 18% trend.
PROFEPA seizes wild animals in Motul, Yucatán
During an inspection visit in response.
In press release, CONAGUA discards versions of “water privatization” in Mexico
The ten Water Reserve Decrees published.
Campeche shows the highest growth in FDI at national level
Campeche was the entity that grew.